195,880$
0,82%
Echtzeit-Aktienkurs Charles River Laboratories International Inc.
Bid:
Ask:
Echtzeit-Chart der Charles River Laboratories International Inc. Aktie
Börsenkurse Charles River Laboratories International Inc.
| New York | - | - | - | - | 195,880$ | 0,82% |
| Lang & Schwarz | - | - | - | - | 187,725€ | -0,21% |
| USA | - | - | - | - | 195,770$ | 4,19% |
| Echtzeit Euro | - | - | - | - | 187,800€ | 1,16% |
| Tradegate | - | - | - | - | 187,900€ | 1,43% |
| Börse Frankfurt | - | - | - | - | 187,075€ | 0,77% |
| Börse Stuttgart | - | - | - | - | 187,800€ | -0,42% |
| gettex | - | - | - | - | 187,925€ | -0,03% |
| Echtzeit USD | - | - | - | - | 197,056$ | 0,66% |
Fundamentaldaten der Charles River Laboratories International Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 4,13 Mrd. | 581,28 Mio. | 474,62 Mio. | - | - | - | 2,44 |
| 2022 [USD] | 3,98 Mrd. | 622,99 Mio. | 486,23 Mio. | - | - | - | 2,51 |
| 2021 [USD] | 3,54 Mrd. | 480,71 Mio. | 390,98 Mio. | - | - | - | 2,79 |
| 2020 [USD] | 2,92 Mrd. | 447,11 Mio. | 364,30 Mio. | - | - | - | 3,33 |
| 2019 [USD] | 2,62 Mrd. | 304,08 Mio. | 252,02 Mio. | - | - | - | 3,66 |
| 2018 [USD] | 2,27 Mrd. | 281,68 Mio. | 226,37 Mio. | - | - | - | 4,17 |
| 2017 [USD] | 1,86 Mrd. | 296,96 Mio. | 123,36 Mio. | - | - | - | 5,00 |
| 2016 [USD] | 1,68 Mrd. | 222,92 Mio. | 154,77 Mio. | - | - | - | 5,52 |
| 2015 [USD] | 1,36 Mrd. | 195,43 Mio. | 149,31 Mio. | - | - | - | 6,71 |
| 2014 [USD] | 1,30 Mrd. | 177,60 Mio. | 126,70 Mio. | - | - | - | 7,14 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Charles River Laboratories International Inc. Aktie
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.